Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents
Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...
Singularity Hub1d
DeepMind and BioNTech Bet AI Lab Assistants Will Accelerate Science
Several companies and labs are betting the latest generation of chatbots could make useful research assistants, accelerating ...
BioNTech SE ADR falls Monday, still outperforms market
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
BioNTech's (NASDAQ:BNTX) investors will be pleased with their massive 749% return over the last five years
While the best companies are hard to find, but they can generate massive returns over long periods. To wit, the BioNTech SE ...
How the rapid development of COVID vaccines prepares us for future pandemics
Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...
WeightWatchers adds compounded version of Novo's obesity drug to weight-loss program
WeightWatchers said on Tuesday it is adding a compounded version of Novo Nordisk's obesity drug Wegovy to its ...
Morgan Stanley Remains a Buy on BioNTech SE (BNTX)
Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of ...
BioNTech (BNTX) Presents at Innovation Series: AI Day
Company Conference Call October 1, 2024 9:00 AM ETCompany ParticipantsKarim Beguir - Chief Executive Officer, InstaDeepUğur ...
DeepMind and BioNTech build AI lab assistants for scientific research
Google DeepMind and BioNTech are building AI lab assistants to help researchers plan scientific experiments and better ...
BioNTech SE (BNTX) Gets a Buy from Deutsche Bank
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on BioNTech SE (BNTX – Research Report), with ...
BioNTech SE ADR rises Friday, outperforms market
The BioNTech SE ADR BNTX advanced 2.40% to $122.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and the ...